These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31675687)

  • 1. Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration.
    Wen Y; Zhang S; Yang J; Guo D
    Biomed Pharmacother; 2019 Dec; 120():109546. PubMed ID: 31675687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide somatic copy number alteration analysis and database construction for cervical cancer.
    Luo H; Xu X; Yang J; Wang K; Wang C; Yang P; Cai H
    Mol Genet Genomics; 2020 May; 295(3):765-773. PubMed ID: 31901979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
    Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
    Elife; 2020 Jan; 9():. PubMed ID: 31939734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.
    Budczies J; Bockmayr M; Denkert C; Klauschen F; Gröschel S; Darb-Esfahani S; Pfarr N; Leichsenring J; Onozato ML; Lennerz JK; Dietel M; Fröhling S; Schirmacher P; Iafrate AJ; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2016 Aug; 55(8):626-39. PubMed ID: 27106868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing.
    Zhao F; Hong J; Zhou G; Huang T; Lin Z; Zhang Y; Liang L; Tang H
    Front Immunol; 2024; 15():1434450. PubMed ID: 39224598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prominence of the Broad-Spectrum Protease inhibitor gene A2ML1 as a potential biomarker in cervical cancer diagnostics using Immunotherapeutic and Multi-Omics approaches.
    Naveed M; Saad Mughal M; Aziz T; Jabeen K; Ali Khan A; Alhomrani M; Alsanie WF; Alamri AS
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113126. PubMed ID: 39265356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulated DSG2 promotes tumor growth and reduces immune infiltration in cervical cancer.
    Zhang G; Chen Z; Wang Y; Huang A; Nie F; Gao L; Wang Y; Ren F
    Pathol Res Pract; 2024 Oct; 262():155554. PubMed ID: 39226803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
    Samur MK; Shah PK; Wang X; Minvielle S; Magrangeas F; Avet-Loiseau H; Munshi NC; Li C
    BMC Genomics; 2013 Oct; 14():672. PubMed ID: 24088394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated approach to reveal miRNAs' impacts on the functional consequence of copy number alterations in cancer.
    Li K; Liu Y; Zhou Y; Zhang R; Zhao N; Yan Z; Zhang Q; Zhang S; Qiu F; Xu Y
    Sci Rep; 2015 Jun; 5():11567. PubMed ID: 26099552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number of 8q24.3 drives HSF1 expression and patient outcome in cancer: an individual patient data meta-analysis.
    Brusselaers N; Ekwall K; Durand-Dubief M
    Hum Genomics; 2019 Nov; 13(1):54. PubMed ID: 31699156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy.
    Yao S; Zhao L; Chen S; Wang H; Gao Y; Shao NY; Dai M; Cai H
    Front Immunol; 2023; 14():1135657. PubMed ID: 36969161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy.
    Roszik J; Ring KL; Wani KM; Lazar AJ; Yemelyanova AV; Soliman PT; Frumovitz M; Jazaeri AA
    Front Immunol; 2018; 9():2102. PubMed ID: 30283446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
    Zhao H; Zhang S; Yin X; Zhang C; Wang L; Liu K; Xu H; Liu W; Bo L; Lin S; Feng K; Lin L; Fei M; Ning S; Wang L
    Front Immunol; 2022; 13():990143. PubMed ID: 36304471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
    Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
    Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.
    Liu W; Jiang Q; Sun C; Liu S; Zhao Z; Wu D
    BMC Cancer; 2022 Feb; 22(1):192. PubMed ID: 35184747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
    Li X; Cai Y
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30445744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
    Wang G; Anastassiou D
    Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative genomic and network analysis identified novel genes associated with the development of advanced cervical squamous cell carcinoma.
    Roychowdhury A; Samadder S; Das P; Mandloi S; Addya S; Chakraborty C; Basu PS; Mondal R; Roy A; Chakrabarti S; Roychoudhury S; Panda CK
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):2899-2911. PubMed ID: 27641506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer.
    Liu L; Bai X; Wang J; Tang XR; Wu DH; Du SS; Du XJ; Zhang YW; Zhu HB; Fang Y; Guo ZQ; Zeng Q; Guo XJ; Liu Z; Dong ZY
    Clin Cancer Res; 2019 Dec; 25(24):7413-7423. PubMed ID: 31515453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.